The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes
Abstract
Objectives To describe the clinical manifestations, cerebrospinal fluid (CSF) characteristics, imaging studies and prognostic factors of adverse clinical outcomes (ACO) among adults with herpes simplex virus (HSV) or varicella zoster virus (VZV) CNS infections.Methods Retrospective review of adult patients with positive HSV or VZV polymerase chain reaction on CSF from an observational study of meningitis or encephalitis in Houston, TX (2004-2014), and New Orleans, LA (1999-2008).Results Ninety-eight adults patients were identified; 25 had encephalitis [20 (20.4 %) HSV, 5 (5.1 %) VZV], and 73 had meningitis [60 (61.1 %) HSV and 13 (13.3 %) VZV]. HSV and VZV had similar presentations except for nausea (P < 0.01) and rash (P < 0.001). The CSF profile did not differ between HSV and VZV infection. Abnormal neuroimaging findings were found in 11.6 % (10/86) brain CTs and 21.3 % (16/75) brain MRIs. The EEG was abnormal in 57.9 % (11/19). Sixteen patients (16.3 %) had an ACO (10 HSV encephalitis, 3 VZV encephalitis and 3 VZV meningitis). Intravenous acyclovir administered within 48 h was protective against an ACO [OR 0.19 (0.04-0.80), P = 0.02). However, on logistic regression only Charlson comorbidity score >1 and an encephalitis presentation were independently associated with an ACO. The treatment for HSV meningitis was variable, and all patients had a good clinical outcome.Conclusion Alpha herpes CNS infections due to HSV and VZV infections have similar clinical and laboratory manifestations. ACO was observed more frequently in those patients with comorbidities and an encephalitis presentation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies assessing prognosis using hard endpoints in the post-acyclovir era showed neurological impairment in 20–60% of patients upon hospital discharge [62–64], 55% after one month, 51% after three months and 71% after one year [62, 65] after the acute episode.”
From Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 (2022) · cites this paper as [63]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
FOSS, M. V. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90810-4 · Cited by 2,904
Venkatesan, A., Tunkel, A. R., Bloch, K. C., Lauring, A. S., Sejvar, J. J., Bitnun, A., Stahl, J. ‐., Mailles, A., DREBOT, M. A., Rupprecht, C. E., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit458 · Cited by 1,247
Tunkel, A. R., Glaser, C. A., Bloch, K. C., Sejvar, J. J., Marra, C. M., Roos, K. L., Hartman, B. J., Kaplan, S. L., Scheld, W. M., & Whitley, R. J. (2008) · Clinical Infectious Diseases · doi:10.1086/589747 · Cited by 1,193
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
Corey, L., ADAMS, H. G., BROWN, Z. A., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-958 · Cited by 928
Lakeman, F. D., & Whitley, R. J. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.857 · Cited by 666
Raschilas, F., Wolff, M., Delatour, F., Chaffaut, C., de Broucker, T., Chevret, S., Lebon, P., Canton, P., Rozenberg, F., & French Herpes Simplex Encephalitis Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/341405 · Cited by 535
Computed tomography of the head before lumbar puncture in adults with suspected meningitis
Hasbun, R., Abrahams, J., Jekel, J., & Quagliarello, V. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010399 · Cited by 462
Self-citationN‐methyl‐ D ‐aspartate receptor antibodies in herpes simplex encephalitis
Prüss, H., Finke, C., Höltje, M., Hofmann, J., Klingbeil, C., Probst, C., Borowski, K., Ahnert‐Hilger, G., Harms, L., Schwab, J. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23689 · Cited by 422
Cited by
Sorted by citations
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management
Bradshaw, M. J., & Venkatesan, A. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0433-7 · Cited by 510
Acute encephalitis in immunocompetent adults
Venkatesan, A., Michael, B. D., Probasco, J. C., Geocadin, R. G., & Solomon, T. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32526-1 · Cited by 195
Epidemiology of meningitis and encephalitis in the United States, 2011–2014
Hasbun, R., Rosenthal, N., Balada-Llasat, J. M., Chung, J., Duff, S., Bozzette, S., Zimmer, L., & Ginocchio, C. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix319 · Cited by 171
Self-citationMeningitis in adults: diagnosis and management
Young, N., & Thomas, M. (2018) · Internal Medicine Journal · doi:10.1111/imj.14102 · Cited by 118
Viral meningitis: current issues in diagnosis and treatment
McGill, F., Griffiths, M. J., & Solomon, T. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000355 · Cited by 101
Metadata
- Authors
- Kaewpoowat, Q., Salazar, L., Aguilera, E., Wootton, S. H., & Hasbun, R.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Corresponding author
- Kaewpoowat, Quanhathai
- Venue
- Infection
- Published
- 2015-12-17
- Volume
- 44
- Issue
- 3
- Pages
- 337-345
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W2216932999
- Cited by
- 109
- References
- 42
- Citations by year
- 2026: 2 · 2025: 16 · 2024: 6 · 2023: 9 · 2022: 12 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 12 · 2017: 14 · 2016: 9
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Infection (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Grant A Starr Foundation
- National Center for Research Resources (NIH-1 K23 RR018929-01A2)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- herpes simplex virus, varicella-zoster virus, herpes simplex encephalitis, adverse clinical outcomes, acyclovir, intravenous antiviral therapy, neuroimaging findings, EEG abnormalities, Charlson Comorbidity Index, prognostic factors, adults
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Meningitis, Viral, Middle Aged, Retrospective Studies, Herpesvirus 3, Human, Treatment Outcome, Simplexvirus, Encephalitis, Herpes Simplex, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
